Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study

Frontiers in Cardiovascular Medicine

Xiaoyu Zhang¹  Juan Xu²  Xiaofeng Lu²  Xintao Li²  Yong Wei²  Shaowen Liu²  Genqing Zhou²  Songwen Chen²  Shi Peng²  Chao Gong²  Bo Guan³ 

[1] Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China;Department of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, China;Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;Geriatric Cardiology Department of the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China;

关键词: heart failure;    Mendelian randomization;    C-reactive protein;    fibrinogen;    interleukin;   

DOI  :  10.3389/fcvm.2021.734400

来源: Frontiers

【 授权许可】

CC BY